Higher Dose Epinephrine: Special Circumstances Only
High-dose epinephrine (0.1-0.2 mg/kg) is NOT recommended for routine cardiac arrest but may be considered in specific toxicological emergencies—specifically β-blocker overdose or calcium channel blocker overdose. 1
Evidence Against Routine High-Dose Use
The American Heart Association provides a Class 3: No Benefit recommendation against high-dose epinephrine in standard cardiac arrest scenarios. 1 Multiple randomized controlled trials have definitively shown that high-dose epinephrine:
- Does NOT improve survival to hospital discharge compared to standard 1 mg dosing 1, 2, 3
- Does NOT improve neurological outcomes at discharge 1, 2, 3
- Does NOT improve survival to hospital admission in most studies 1
- May increase return of spontaneous circulation (ROSC) temporarily, but this does not translate to meaningful survival benefit 1, 3
The European Epinephrine Study Group trial (n=3,327 patients) found that while high-dose epinephrine (5 mg) improved ROSC rates (40.4% vs 36.4%, p=0.02), there was no difference in survival to discharge (2.3% vs 2.8%, p=0.34). 3
The Critical Problem: Post-Arrest Harm
The adverse effects of higher doses of epinephrine in the post-arrest period negate any potential advantages during the intra-arrest period. 1 High-dose epinephrine may worsen post-resuscitation myocardial dysfunction through excessive β-adrenergic stimulation, increasing myocardial oxygen demand and reducing subendocardial perfusion. 1
Observational data from 946 cardiac arrest patients demonstrates that increasing cumulative epinephrine doses are independently associated with worse outcomes—each quartile increase in cumulative dose showed progressively higher odds ratios for unfavorable functional outcome (OR 1.0-1.45-2.25-2.95) and in-hospital mortality (OR 1.0-1.35-2.15-2.82). 4
When High-Dose May Be Appropriate
The 2015 AHA Guidelines specifically identify two toxicological scenarios where high-dose epinephrine may be reasonable:
In these poisoning scenarios, the standard 1 mg dose may be insufficient to overcome receptor blockade or calcium channel antagonism. 1
Alternatively, epinephrine may be titrated to real-time physiologically monitored parameters (such as arterial pressure monitoring during CPR), though this approach lacks robust evidence. 1
Standard Dosing Remains the Evidence-Based Approach
Standard-dose epinephrine (1 mg IV/IO every 3-5 minutes) is the recommended approach for all routine cardiac arrest scenarios (Class IIb, Level of Evidence B-R). 1, 5
For pediatric patients, the standard dose is 0.01 mg/kg (maximum 1 mg) repeated every 3-5 minutes, and high-dose epinephrine (>10 mcg/kg) has similarly shown no survival benefit. 6, 5
Common Pitfalls to Avoid
- Do not escalate to high-dose epinephrine in standard cardiac arrest simply because standard doses are not achieving ROSC—this will not improve survival and may worsen neurological outcomes 1
- Do not confuse continuous infusion dosing (0.1-1.0 μg/kg/min for shock states) with high-dose bolus therapy during cardiac arrest 6, 7
- Ensure adequate volume resuscitation before escalating vasopressor doses in any clinical scenario 7
- Recognize that cumulative doses above 3 mg during resuscitation are associated with unfavorable neurological outcomes 5, 4